Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 18,198 shares at $55.52 ($1.0M) on 2026-07-27, disclosed to the SEC on 2026-07-28.
Scheduled sale ($1.0M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.52 | 11,783 | $654K | 64.6% |
| 2 | $55.52 | 756 | $42K | 4.1% |
| 3 | $55.54 | 622 | $35K | 3.4% |
| 4 | $55.91 | 378 | $21K | 2.1% |
| 5 | $55.93 | 4,415 | $247K | 24.4% |
| 6 | $55.96 | 244 |
| $14K |
| 1.3% |
| Total | $55.63 avg | 18,198 | $1.0M | 100% |
| Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |
| PCVX | SELL | 2024-11-08 | $246K | — | Filing → |